Modular Texts Series Series

Pandemic Influenza Edition 2

Paperback
February 2013
9781845938574
More details
  • Publisher
    CABI
  • Published
    15th February 2013
  • ISBN 9781845938574
  • Language English
  • Pages 264 pp.
  • Size 7" x 10"
  • Images 37 illus
  •    Request Exam Copy
$91.00
Hardback
February 2013
9781845938567
More details
  • Publisher
    CABI
  • Published
    15th February 2013
  • ISBN 9781845938567
  • Language English
  • Pages 264 pp.
  • Size 7" x 10"
  • Images 37 illus
  •    Request Exam Copy
$206.40

Pandemic influenza is an emerging pathogen that has serious public health consequences. Following recent avian and swine influenza outbreaks, preparedness against pandemic influenza on national and international scales is of vital importance. With a strong emphasis on practicality, this book covers areas such as influenza epidemiology, virology and immunology, vaccinology, pharmaceutical and public health countermeasures, policy issues, biomathematical modeling and ethics. Each chapter raises five key questions and answers them in clear and concise sections, detailing relevant model studies and providing select papers for further reading. Updated throughout, this second edition contains new contributions on surveillance, international regulations and local pandemic responses.

Contributors
Editor Biographies
Foreword
Acknowledgements
Glossary

1. Epidemiology and clinical features of interpandemic influenza
2. Influenza surveillance and pandemic requirements, basic influenza virology and immunology
3. Influenza in birds and mammals
4. History and epidemiological features of pandemic influenza
5. Epidemiology of pandemic influenza A(H1N1)pdm09
6. Clinical features and treatment of pandemic influenza A(H1N1)pdm09
7. Influenza transmission and infection control issues
8. Pandemic preparedness
9. Emergency preparedness and business continuity planning
10. The role of exercises in pandemic preparedness
11. Local health services responses to the 2009 pandemic
12. Bio-mathematical modelling and pandemic preparedness
13. Pharmaceutical Interventions
14. Pandemic vaccines
15. National and international public health measures
16. Port Health and International Health Regulations
17. Socio-economic impact
18. Ethical issues related to pandemic preparedness and response
19. Pandemic Communication

Case Study 1: Mexico
Case Study 2: Chile
Case Study 3: New Zealand
Case Study 4: The former Soviet Union
Case Study 5: Africa
Case Study 6: Denmark
Case Study 7: South East Asia
Case Study 8: North America
Case Study 9: Saudi Arabia

Index

Jonathan Van-Tam

Jonathan Van-Tam is Professor of Health Protection at City Hospital, Nottingham.

Chloe Sellwood

Chloe Sellwood works for the UK National Health Service (NHS) Strategic Health Authority (SHA) in London where she is the Pandemic Influenza Lead. She graduated in biochemistry in 1998 and completed a PhD in plant biochemistry in 2001. Her experience in pandemic preparedness ranges from international to local level, and encompasses both scientific and operational aspects. She spent over 7 years at the Health Protection Agency Centre for Infections, including 3 years as the Senior Scientist and Coordinator of the Pandemic Influenza Office from 2005 to 2008. She has worked with the WHO and the ECDC on international consultations, as well as on secondment to the Department of Health in England's Pandemic Influenza Preparedness Program. In her current role she is responsible for the strategic overview of influenza pandemic preparedness within the NHS in London.